Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis
Authors:
- M.S. MuhlebachMMM.S. Muhlebach
- for the STAR‐CF Study TeamFTfor the STAR‐CF Study Team
- 14 June 2013
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 49 (3) , 230-237
Abstract
Summary: Objectives: The prevalence of methicillin‐resistant Staphylococcus aureus (MRSA) in cystic fibrosis (CF) patients in the United States is approximately 25%. Little is known about the relative proportion of hospital‐ versus community‐associated strains or the antimicrobial susceptibility of MRSA in different CF centers. We hypothesized that the majority of MRSA isolates obtained from children with CF are those endemic in the hospital and that those associated with community acquisition (SCCmec IV) would be more resistant than typically seen in non‐CF MRSA isolates.Methods: We studied MRSA strains from seven pediatric CF centers to determine the clonal distribution based on DNA sequencing of the staphylococcal protein A gene (spa typing), the type of staphylococcal chromosomal cassette mec (SCCmec), and the proportion of strains with Panton‐Valentine leukocidin (PVL). Antimicrobial susceptibility to systemic and topical antibiotics was compared between different MRSA types.Results: We analyzed 277 MRSA isolates from unique patients (mean age 11.15 ± 4.77 years, 55% male). Seventy % of isolates were SCCmec II PVL negative and the remainder SCCmec IV. Overall 17% MRSA strains were PVL positive (all SCCmec IV). Spa typing of 118 isolates showed most of the SCCmec II strains being t002, while SCCmec IV PVL positive isolates were t008, and SCCmec IV PVL negative isolates represented a variety of spa‐types. The proportions of SCCmec II strains and spa‐types were similar among centers. Overall rates of resistance to trimethoprim–sulfamethoxazole (4%), tetracycline (7%), tigecycline (0.4%), linezolid (0.4%) as well as fosfomycin (0.4%), fusidic acid (3%), and mupirocin (1%) were low. No strains were resistant to vancomycin. SCCmec II strains had higher rates of resistance to ciprofloxacin and clindamycin (P < 0.001) than SCCmec IV strains.Conclusions: In this U.S. study, most MRSA isolates in the pediatric CF population were SCCmec II PVL negative. Rates of resistance were low, including to older and orally available antibiotics such as trimethoprim–sulfamethoxazole. Pediatr Pulmonol. 2014; 49:230–237.Keywords
Funding Information
- Cystic Fibrosis Foundation Therapeutics (MUHLEB08A0)
This publication has 30 references indexed in Scilit:
- Association Between Respiratory Tract Methicillin-Resistant Staphylococcus aureus and Survival in Cystic FibrosisJAMA, 2010
- Persistent Methicillin-resistant Staphylococcus aureus and Rate of FEV1 Decline in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Characterization of Staphylococcus aureus Isolates from Nasal Cultures Collected from Individuals in the United States in 2001 to 2004Journal of Clinical Microbiology, 2008
- Methicillin resistant staphylococcus aureus in cystic fibrosisPediatric Pulmonology, 2008
- Panton-Valentine Leukocidin-Positive Methicillin-Resistant Staphylococcus aureus Lung Infection in Patients With Cystic FibrosisChest, 2007
- Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung functionPediatric Pulmonology, 2007
- Evidence for airway surface dehydration as the initiating event in CF airway diseaseJournal of Internal Medicine, 2007
- Fifteen-Year Study of the Changing Epidemiology of Methicillin-Resistant Staphylococcus aureusThe American Journal of Medicine, 2006
- Microbiology of early CF lung diseasePaediatric Respiratory Reviews, 2004
- Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the CommunityJournal of Clinical Microbiology, 2002